These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8552419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
    al-Yaman F, Genton B, Kramer KJ, Chang SP, Hui GS, Baisor M, Alpers MP.
    Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
    [Abstract] [Full Text] [Related]

  • 3. Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status.
    al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP.
    Parasite Immunol; 1997 May; 19(5):207-14. PubMed ID: 9194097
    [Abstract] [Full Text] [Related]

  • 4. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea.
    al-Yaman F, Genton B, Falk M, Anders RF, Lewis D, Hii J, Beck HP, Alpers MP.
    Am J Trop Med Hyg; 1995 Jan; 52(1):66-71. PubMed ID: 7856827
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR, Allen SJ, Greenwood BM, Riley EM.
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [Abstract] [Full Text] [Related]

  • 8. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.
    Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
    [Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.
    Genton B, Al-Yaman F, Anders R, Saul A, Brown G, Pye D, Irving DO, Briggs WR, Mai A, Ginny M, Adiguma T, Rare L, Giddy A, Reber-Liske R, Stuerchler D, Alpers MP.
    Vaccine; 2000 May 22; 18(23):2504-11. PubMed ID: 10775784
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C, Frank G, Smith T, Jafarshad A, Nebie I, Sirima SB, Olugbile S, Alonso P, Tanner M, Druilhe P, Felger I, Corradin G.
    Vaccine; 2009 May 05; 27(20):2653-61. PubMed ID: 19428875
    [Abstract] [Full Text] [Related]

  • 11. Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area.
    al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP.
    Parasite Immunol; 1997 Jun 05; 19(6):249-54. PubMed ID: 9364554
    [Abstract] [Full Text] [Related]

  • 12. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003 Jun 05; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 13. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.
    Stirnadel HA, Beck HP, Alpers MP, Smith TA.
    Genet Epidemiol; 1999 Jun 05; 17(1):16-34. PubMed ID: 10323182
    [Abstract] [Full Text] [Related]

  • 14. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB, Anders RF, Beeson JG, Färnert A, Kironde F, Berenzon SK, Wahlgren M, Linse S, Persson KE.
    PLoS One; 2012 Jun 05; 7(2):e32242. PubMed ID: 22363818
    [Abstract] [Full Text] [Related]

  • 15. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi TW, Marsh K.
    Vaccine; 2006 May 08; 24(19):4233-46. PubMed ID: 16111789
    [Abstract] [Full Text] [Related]

  • 16. WITHDRAWN: Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2007 Jul 18; 2003(4):CD000129. PubMed ID: 17636596
    [Abstract] [Full Text] [Related]

  • 17. Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal.
    Sarr JB, Pelleau S, Toly C, Guitard J, Konaté L, Deloron P, Garcia A, Migot-Nabias F.
    Microbes Infect; 2006 Apr 18; 8(5):1260-8. PubMed ID: 16679042
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
    Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, Lamptey H, Egyir B, Oduro AR, Gyan B, Hodgson A, Koram KA.
    Malar J; 2011 May 01; 10():108. PubMed ID: 21529376
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.
    Badaut C, Guyonnet L, Milet J, Renard E, Durand R, Viwami F, Sagbo G, Layla F, Deloron P, Bonnefoy S, Migot-Nabias F.
    Malar J; 2015 Jul 16; 14():278. PubMed ID: 26178656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.